All News

A leader in urologic oncology discusses four currently available molecular tests in this report from Urology Times SUO internship program member Brandon Manley, MD.

In a recently published study, researchers analyzed data from nearly 20,000 high-risk prostate cancer patients at more than 1,000 facilities.

Findings from a recent study emphasize the need for imaging with CT or MRI and bone scan to determine the pattern of spread in men with advanced prostate cancer.

Physician assistant Lisa Kerr, PA-C, shares techniques for improved patient understanding and care.

Since graduating from medical school, one of the most prevalent commentaries I have heard about health policy is “Fee-for-service is going away.” Depending on the commentator’s level of cynicism, that would be followed with either “You won’t be able to make a living in medicine anymore” or the milder “It’ll be interesting to see what happens.” Read more on Dr. Kaplan's insight on fee-for-service and what it means.

Every year, September through January is both an exciting and anxious time for fourth-year medical students and urology residency programs alike. With the conclusion of the 2016 urology match season this past January, I felt the same exhilaration that I did just 3 years ago. This year, however, I had the privilege to reflect on the demanding application process from the lens of an interviewer rather than that of an interviewee. Read more from Nirmish Singla, MD

Urologists should never feel as though they do not or cannot influence decisions that impact their patients and profession. Martin K. Dineen, MD, shares his insighst on the latest changes in government regulations, payer policies, and how you can get involved and make a difference.

During my second year as a urology resident, I walked into my mid-year evaluation meeting with my chairman, threw my hands up in the air, and told him I wasn’t happy with how I was operating. When I later reviewed my chairman’s dictated letter regarding our meeting, he wrote, “She has a lot of self-awareness.” While the remainder of the letter was also very complimentary, this single phrase really stuck out and was perhaps the most meaningful comment in the document. Learn more about Dr. Amy Pearlman's journey to becoming self-aware and why it's important.

Check out the latest products. From an MRI System that improves lesion conspicuity, a biopsy device receives FDA clearance and an App that tracks stent implants.

Peter C. Black, MD, discusses the current state of immune checkpoint inhibition for bladder cancer in this article from Urology Times SUO internship program member William Parker, MD.

Urology Times SUO internship program member Robert M. Turner, II, MD, reports on a recent presentation by J. Stuart Wolf, Jr., MD, about possible pitfalls of renal mass biopsy.

Lower urinary tract symptoms (LUTS) are not just a problem with staying asleep. Difficulty with sleep may actually impact LUTS, say researchers at Baylor College of Medicine in Houston.

Surveillance “should be more commonly used for patients with low-risk prostate cancer,” argues an author of the endorsement.

Physicians at Vanderbilt University Medical Center, Nashville, have opened a dedicated cardio-oncology service, including urology, medical oncology, radiation oncology, and cardiology.

Nurse practitioner Adele M. Caruso, MSN, CRNP, discusses appropriate timing of follow-up and ponders related health insurance coverage and cancer survivorship issues.

A recent a White House Dialogue on Men’s Health brought together experts on men’s health from government, professional sports, nonprofit organizations, and health care, who together raised awareness of the need for increased focus on men’s health.

The Protecting Americans from Tax Hikes Act of 2015 was signed into law on Dec. 18, 2015. The law renews a long list of tax breaks known as “extenders” that have been expiring on an annual basis.

"What we need most are markers that selectively identify significant cancers, in order to reduce unnecessary biopsies and over-diagnosis," writes Stacy Loeb, MD, MSc.

Two urinary biomarkers for detection of prostate cancer have differing utility in African-American men undergoing prostate biopsy.

Urologists have direct experience with drug shortages and their impact on pricing, thanks to the recent shortage of BCG. A sudden hike in the price of a competing generic drug seemed to be no coincidence, Henry Rosevear, MD, writes. He ponders a few similar, troubling cases and some proposed solutions.

Peyronie’s disease (PD) is surgically treated by a minority of urologists, and urologists who subspecialize in andrology perform a disproportionate number of procedures to treat the condition. Those were among the findings of a case-log analysis that was presented at the 2015 AUA annual meeting in New Orleans and subsequently published in Urology (2016; 87:205-9).

The purpose of this article is to provide a clear understanding of the basis for the genetic and epigenetic tools that are increasingly used in medicine, highlight some of these tools currently used in urology, and explain the clinical and medicolegal ramifications of direct-to-consumer tests.

In this article, I will describe some nuances of buy and bill that you should understand in your roles of small business owner and treatment provider, especially as it pertains to Medicare.

New findings from the Johns Hopkins University School of Medicine in Baltimore should be useful to clinicians looking to counsel anxious prostate cancer patients who are undergoing active surveillance.

In this latest installment of "Coding Q&A," Ray Painter, MD, and Mark Painter also discuss compensation plans and answer a question regarding CPT 76942 and 50200.

Most men with anterior urethral strictures are treated without imaging, and 90% are not being offered urethroplasty.

In this column, I will discuss expert witnesses and preparing for trial in a medical malpractice case.

Once considered a primary option for kidney stone treatment, shock wave lithotripsy appears to be losing traction. Many urologists say its outcomes aren’t as reliable as those from ureteroscopy. But others say it remains an option that works well with proper patient selection and technique and offers what ureteroscopy doesn’t: a noninvasive option.

Telemedicine may provide the answer to costly consultations. According to data from a recent study, remote video visits demonstrated equivalent efficiency and satisfaction when compared with traditional office visits for men with surgically treated prostate cancer.